Bristol wins EU green light for immune system cancer drug
April 24, 2015 at 07:17 AM EDT
LONDON, April 24 (Reuters) - European regulators have recommended approval of Bristol-Myers Squibb's Opdivo, paving the way for it to become the first of a closely watched group of immune system-boosting cancer medicines to go on sale in Europe.